Pathophysiological aspects of oxygen, hypoxia and free radical oxidation in critical conditions

Cover Page

Cite item

Full Text

Abstract

Oxygen is the main regulator of metabolic processes in the body not only in the context of normal physiology, but also in the development of various critical conditions.

In recent years, the problem of pathogenesis of a number organs' and systems' diseases has been enriched by knowledge of the mechanism of damage to cellular structures. Oxygen turned out to be the main factor of damage — the very oxygen, due to the lack of which cell death occurs. It turned out that the so-called reactive oxygen species having an unpaired electron have a biological effect, which, depending on the concentration, can be regulatory or, conversely, toxic. Accordingly, interest has also been aroused in compounds that normally prevent the toxic effect of reactive oxygen species — antioxidants. Today it is generally recognized that oxidative stress plays an important and possibly a key role in the pathogenesis of critical conditions. Thus, on the one side, excessive production of free radicals is considered as one of the manifestations of the body's protective reaction to the effects of various environmental factors and living conditions (infections, injuries, toxins, ionizing radiation, physical stress, hypothermia, hypoxia, various types of stress), on the other ― increased production of free radicals quickly leads to irreversible damage: destruction of the erythrocytes' membranes with subsequent hemolysis, transformation of hemoglobin into methemoglobin, DNA damage, desensitization of plasma membrane receptors, inactivation of various hormones and enzymes, including antiradical and antiperoxide protection enzymes.

The problem of using oxygen in critical conditions is currently widely discussed in the periodical literature with an emphasis on the oxygen concentrations used in patients, both in operating rooms and in intensive care units. Oxygen used in the intensive care of acute respiratory failure and hypoxia should have a certain concentration range. The toxic effects of oxygen can occur with its prolonged use in high concentrations, which causes not only its direct toxic effect on the lungs, but also in the potentiation of the activation of free radical oxidation and excessive production of reactive oxygen species.

The review presents current data on the physiological role of oxygen, its participation in metabolic processes against the background of inflammation, hypoxia and under conditions of activation of free radical oxidation processes. The recent approach to oxygen therapy and the research data presented in the review urge to relate to oxygen as a drug in order to avoid manifestations of its toxic effects.

About the authors

Yurii P. Orlov

Omsk State Medical University

Email: orlov-up@mail.ru
ORCID iD: 0000-0002-6747-998X
SPIN-code: 3811-7817

MD, Dr. Sci. (Med.), Assistant Professor

Russian Federation, Omsk

Sergey V. Sviridov

The Russian National Research Medical University named after N.I. Pirogov

Email: sviridov.ru@mail.ru
ORCID iD: 0000-0002-9976-8903
SPIN-code: 4974-9195

MD, Dr. Sci. (Med.), Professor

Russian Federation, Moscow

Evgeny N. Kakulya

Omsk State Medical University

Author for correspondence.
Email: vrach2248@yandex.ru
ORCID iD: 0000-0002-2811-6051
SPIN-code: 5953-4315

к.м.н., ассистент кафедры анестезиологии и реаниматологии Омского государственного медицинского университета

 

Russian Federation, Omsk

References

  1. Bosco G, Paganini M, Giacon TA, et al. Oxidative stress and inflammation, MicroRNA, and hemoglobin variations after administration of oxygen at different pressures and concentrations: a randomized trial. Int J Environ Res Public Health. 2021;18(18):9755. doi: 10.3390/ijerph18189755
  2. Douin DJ, Anderson EL, Dylla L, et al. Association between hyperoxia, supplemental oxygen, and mortality in critically injured patients. Critical Care Explorations. 2021;3(5):e0418. doi: 10.1097/CCE.0000000000000418
  3. Hsia CC, Schmitz WA, Lambertz M, et al. Evolution of air breathing: oxygen homeostasis and the transitions from water to land and sky. Compr Physiol. 2013;3(2):849–915. doi: 10.1002/cphy.c120003
  4. Vladimirov YA, Archakov AI. Lipid peroxidation in biological membranes. Moscow: Nauka; 1972. 252 p. (In Russ).
  5. Karbyshev MS, Abdullaev ShP. Biochemistry of oxidative stress: an educational and methodical manual. Ed. by A.V. Shestopalov. Moscow; 2018. 60 p. (In Russ).
  6. Vladimirov YuA, Azizova OA, Deev A.I. Free radicals in living systems. Results of science and technology. Biophysics series. Vol. 29. Moscow; 1992. 250 p. (In Russ).
  7. Lysko AI, Dudchenko AM. Catalytic antioxidants: potential therapeutic agents for the correction of pathologies caused by oxidative stress. Pathogenesis. 2013;11(3):22–28. (In Russ).
  8. Semenza GL. HIF-1 and human disease: one highly involved factor. Genes Dev. 2000;14(16):1983–1991.
  9. Lukyanova LD. Modern problems of adaptation to hypoxia. Signaling mechanisms and their role in systemic regulation. Pathological Physiology Experimental Therapy. 2011(1):3–19. (In Russ).
  10. Bitterman H. Bench-to-bedside review: oxygen as a drug. Crit Care. 2009;1(1):205. doi: 10.1186/cc7151
  11. Koskenkorva-Frank TS, Weiss G, Koppenol WH, Burckhardt S. The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med. 2013;65:1174–1194. doi: 10.1016/j.freeradbiomed.2013.09.001
  12. Kalyanaraman B. Teaching the basics of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms. Redox Biol. 2013;1(1):244–257. doi: 10.1016/j.redox.2013.01.014
  13. Morel O, Perret T, Delarche N, et al. Pharmacological approaches to reperfusion therapy. Cardiovasc Res. 2012;94(2):246–252. doi: 10.1093/cvr/cvs114
  14. Yankovsky OY. Oxygen toxicity and biological systems: evolutionary, ecological and biomedical aspects. Saint Petersburg: Game; 2000. 294 р. (In Russ).
  15. Vinchi F, Tolosano E. Therapeutic approaches to limit hemolysis driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis. Oxid Med Cell Longev. 2013;2013:396527. doi: 10.1155/2013/396527
  16. Orlov YP, Govorova NV, Nocturnal YA, Rudnov VA. Anemia of inflammation: features, necessity and possibility of correction. Literature review. Bulletin Intensive Therapy Named After A.I. Saltanov. 2019;(1):20–35. (In Russ). doi: 10.21320/1818-474X-2019-1-20-35
  17. Zaichik AS, Churilov LP. Fundamentals of pathochemistry. Textbook for medical university students. Saint Petersburg: ALBI; 2001. 688 р. (In Russ).
  18. Moffett JW, Zika RG. Reaction kinetics of hydrogen peroxide with copper and iron in seawater. Environ Sci Technol. 1987;21(8): 804–810. doi: 10.1021/es00162a012
  19. Aghajanyan NA, Bayevsky RM, Berseneva AP. Problems of adaptation and the doctrine of health. Moscow: RUDN; 2006. 284 p. (In Russ).
  20. Litvitsky PF. Hypoxia. Issues Modern Pediatrics. 2016;15(1): 45–58. (In Russ). doi: 10.15690/vsp.v15i1.1499
  21. Ke ZW, Jiang Y, Bao YP, et al. Intensivists’ response to hyperoxemia in mechanical ventilation patients: The status quo and related factors. World J Emerg Med. 2021;12(3):202–206. doi: 10.5847/wjem.j.1920-8642.2021.03.007
  22. Azad P, Stobdan T, Zhou D, et al. High-altitude adaptation in humans: from genomics to integrative physiology. J Mol Med (Berl). 2017;95(12):1269–1282. doi: 10.1007/s00109-017-1584-7
  23. Pham K, Parikh K, Heinrich EC. Hypoxia and inflammation: insights from high-altitude physiology. Front Physiol. 2021;12:676782. doi: 10.3389/fphys.2021.676782
  24. Longo LD. Sir Joseph Barcroft: one victorian physiologist’s contributions to a half century of discovery. J Physiol. 2016;594(5): 1113–1125. doi: 10.1113/JP270078
  25. Grocott MP, Martin DS, Levett DZ, et al.; Caudwell Xtreme Everest Research Group. Arterial blood gases and oxygen content in climbers on Mount Everest. N Engl J Med. 2009;360(2):140–149. doi: 10.1056/NEJMoa0801581
  26. Lukyanova LD. Signaling mechanisms of hypoxia. Moscow: RAS; 2019. 215 р. (In Russ).
  27. Hirota K. Basic biology of hypoxic responses mediated by the transcription factor HIFs and its implication for medicine. Biomedicines. 2020;8(2):32. doi: 10.3390/biomedicines8020032
  28. Hirota K. An intimate crosstalk between iron homeostasis and oxygen metabolism regulated by the hypoxia-inducible factors (HIFs). Free Radic Biol Med. 2019;133:118–129. doi: 10.1016/j.freeradbiomed.2018.07.018
  29. Chen TT, Maevsky EI, Uchitel ML. Maintenance of homeostasis in the aging hypothalamus: the central and peripheral roles of succinate. Front Endocrinol (Lausanne). 2015;6:7. doi: 10.3389/fendo.2015.00007
  30. Singer M. The role of mitochondrial dysfunction in sepsis-induced multiorgan failure. Virulence. 2014;5(1):66–72. doi: 10.4161/viru.26907
  31. Singer M, De Santis V, Vitale D, Jefcoate W. Multiorgan failure is an adaptive, endocrineemediated, metabolic response to overwhelming systemic infammation. Lancet. 2004;364(9433):545–548. doi: 10.1016/S0140-6736(04)16815-3
  32. Hirota K. Hypoxia-dependent signaling in perioperative and critical care medicine. J Anesth. 2021;35(5):741–756. doi: 10.1007/s00540-021-02940-w

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Orlov Y.P., Sviridov S.V., Kakulya E.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies